S H Kelkar & Company Ltd
Q4 FY26 Earnings Call Analysis
Chemicals & Petrochemicals
fundraise: No informationcapex: Yesrevenue: Category 3margin: Category 3orderbook: No information
💰fundraise
Any current/future new fundraising through debt or equity?
- The transcript does not mention any current or planned fundraising through debt or equity.
- The company is focusing on managing existing debt, which stood at Rs. 703 crore as of December 31, 2024.
- Debt increase recently is attributed mainly to inventory replenishment post the Q1 fire incident, capital expenditure, and GST refund delays.
- Management highlighted expectations of debt reduction by about Rs. 100 crore in the next 6 months, aided by insurance payouts.
- Investments are ongoing but appear to be funded through internal accruals and existing debt facilities.
- No explicit plans were shared regarding fresh debt or equity raising in the near or medium term during the Q3 & 9M FY25 concall.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- The company has completed major investments in development and production capacities for its Flavours business and expects this phase to be finished for the current size.
- Further investments in the Flavours business are anticipated in the next 2 years to support continued growth.
- Recent investments include setting up creative development centers in Europe (UK and Germany) and the USA, focusing on product development teams to serve local and global MNC markets.
- Capital expenditure of around Rs. 75 crore has been incurred for rebuilding a factory after a fire, expected to be reimbursed substantially through insurance.
- The company invested approximately Rs. 45-48 crore in FY25 towards development centers and expects this cost to stabilize and grow only by inflation thereafter.
- There are plans to invest in European production capacity within the next 1–2 years to support sales momentum and capacity utilization.
- No plans to expand beyond the current four major markets (Southeast Asia, India, Middle East, Europe, and America) in the near to medium term.
📊revenue
Future growth expectations in sales/revenue/volumes?
- Company targets a 12% CAGR growth over the mid to longer term, with recent 9-month performance ahead at nearly 17% YoY growth.
- Expectation of reaching around Rs. 3,000 crore revenue by FY27, implying approximately 14% CAGR.
- Major growth contribution expected from volume increases rather than price hikes.
- Flavours business anticipated to grow at a strong +15% CAGR, faster than the more mature Fragrance business.
- European business growing healthily at around 12% annually, outpacing the ~2% market average, with potential capacity expansion planned within 1-2 years.
- New investments in development and production capacity across key geographies (Europe, US, SE Asia) to support higher growth from 18-24 months onwards.
- Momentum in India remains robust (~15% YoY growth), with expected growth pickup in early FY26 due to government initiatives boosting consumption.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- The company expects to maintain a healthy top-line growth of 12% CAGR over the mid to longer term, with FY25 ahead at ~17%.
- EBITDA margins excluding new geography investments stand at a healthy 17%, with an overall margin guidance of 16%-18% for the upcoming year, despite current subdued margins due to investments.
- Gross margins are expected to normalize and improve over the next year as pricing actions take effect and raw material supply stabilizes.
- Investments in Europe, US, and other markets are strategic for long-term growth, expected to drive higher market share, operating leverage, and sustained value creation over the next 3 years.
- Flavours segment delivering strong EBIT (~22%) and growth, expected to contribute to margin expansion as growth accelerates.
- Development expenditure (~Rs. 45-48 crore in FY25) will stabilize, with inflation-adjusted increases thereafter, supporting steady earnings growth.
- Overall, earnings and EPS growth are expected to benefit from volume-driven revenue growth, margin expansion, and cost normalization.
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
- The transcript does not explicitly mention the exact current or expected order book or pending orders.
- However, the company indicates strong demand and growth prospects despite some slowdown in larger Indian domestic accounts.
- Kedar Vaze highlights a robust 15% year-on-year quarterly growth with no slowdown seen so far.
- The business is gaining market share, especially in new geographies like Southeast Asia, Middle East, Europe, and the US.
- New client engagements and product developments are ongoing, supporting a 12%-14% revenue growth guidance.
- For the global MNC account, business is on track to reach $10 million this year, with expected growth of 20%-30% going forward.
- Inventory replenishment and new investments suggest positive order fulfillment outlook, though precise order backlog figures are not disclosed.
